MOXICLOPRID 20 Solution

Kraj: Kanada

Język: francuski

Źródło: Health Canada

Składnik aktywny:

Moxidectine; Imidaclopride

Dostępny od:

MODERN VETERINARY THERAPEUTICS LLC

Dawkowanie:

25MG; 100MG

Forma farmaceutyczna:

Solution

Skład:

Moxidectine 25MG; Imidaclopride 100MG

Droga podania:

Topique

Sztuk w opakowaniu:

15G/50G

Typ recepty:

Prescription

Grupa terapeutyczna:

Chiens

Podsumowanie produktu:

Numéro de groupe d'ingrédients actifs (GIA) :0250439006

Status autoryzacji:

APPROUVÉ

Data autoryzacji:

2021-12-31

Ulotka dla pacjenta

MVT Revisions: December 6 2021
Moxicloprid
TM
55
(imidacloprid and moxidectin topical solution)
(solution topique d’imidaclopride et de moxidectine)
Topical parasiticide
Parasiticide topique
VETERINARY USE ONLY
USAGE VÉTÉRINAIRE SEULEMENT
For dogs weighing 9.1 TO 25 KG.
Pour chiens pesant DE 9,1 À 25 KG.
Active Ingredients per tube: 250 mg imidacloprid and 62.5 mg
moxidectin
Ingrédients actifs dans chaque tube: 250 mg d’imidaclopride et 62.5
mg
de moxidectine
SEE PACKAGE INSERT FOR FULL PRODUCT INFORMATION.
VOIR LA NOTICE DANS LA BOÎTE POUR DES INFORMATIONS COMPLÈTES SUR LE
PRODUIT.
WARNING: KEEP THIS PRODUCT, AND ALL DRUGS, OUT OF REACH OF CHILDREN.
SEE PACKAGE INSERT FOR COMPLETE WARNINGS.
MISE EN GARDE: GARDEZ CE PRODUIT, ET TOUS LES MÉDICAMENTS, HORS DE
LA
PORTÉE DES ENFANTS. VOIR LA NOTICE POUR LES MISES EN GARDE
COMPLÈTES.
PR
Moxicloprid
TM
55
(
imidacloprid and moxidectin topical solution)
(solution topique d’imidaclopride et de moxidectine)
Moxicloprid
TM
55
(imidacloprid and moxidectin topical solution)
(solution topique d’imidaclopride et de moxidectine)
DIN XXXXXXXX
For dogs weighing 9.1 TO 25 KG.
Pour chiens pesant DE 9,1 À 25 KG.
INDICATIONS:
MOXICLOPRID
TM 55 is indicated for the prevention
of cardiovascular dirofilariosis (HEARTWORM disease)
caused by _Dirofilaria immitis _and angiostrongylosis
(FRENCH HEARTWORM) caused by L4 larvae and
immature adults of _Angiostrongylus vasorum_, for the
treatment and control of the adult stage of FOX
LUNGWORM (_Crenosoma vulpis_), the treatment and
control of parasitic infestations caused by the adult
stage of the COMMON FLEA (_Ctenocephalides felis)_, EAR
MITES (_Otodectes cynotis_), SARCOPTIC MANGE MITES
(_Sarcoptes scabiei var. canis_), and as an aid in the
treatment and control of GENERALIZED DEMODECTIC
MANGE (_Demodex canis_).
MOXICLOPRID
TM 55 is also indicated for the treatment
and control of parasitic infections caused by the
developing L4, the sexually immature adult and the
adult stages of HOOKWORMS (_Ancylostoma caninum _
and